Assyro AI

FDA Orange Book · active-ingredient family

Ropinirole hydrochloride

Ropinirole hydrochloride is approved as 2 brand and 21 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:REQUIP XL · NDA 022008

2

Brand (NDA)

21

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, tablet, extended release

ProductApplicantApplicationTEApproved
REQUIP XLRLD×6GLAXOSMITHKLINE LLCNDA 022008Jun 13, 2008
REQUIPRLD×7GLAXOSMITHKLINE LLCNDA 020658Sep 19, 1997

Generic (ANDA) products (21)

ProductApplicantApplicationTEApproved
ROPINIROLE HYDROCHLORIDE×5ELITE LABS INCANDA 217862ABNov 10, 2025
ROPINIROLE HYDROCHLORIDE×5PRINSTON INCANDA 204413ABMay 11, 2022
ROPINIROLE HYDROCHLORIDE×7ACCORD HLTHCAREANDA 204022ABFeb 28, 2017
ROPINIROLE HYDROCHLORIDE×5ALEMBICANDA 202786ABApr 22, 2013
ROPINIROLE HYDROCHLORIDE×7ORBION PHARMSANDA 079229ABNov 28, 2012
ROPINIROLE HYDROCHLORIDE×6AUROBINDO PHARMA USAANDA 200462Oct 15, 2012
ROPINIROLE HYDROCHLORIDE×5CHARTWELL RXANDA 091395ABAug 27, 2012
ROPINIROLE HYDROCHLORIDE×5DR REDDYS LABS LTDANDA 201576ABJun 06, 2012
ROPINIROLE HYDROCHLORIDE×5SANDOZ INCANDA 201047ABJun 06, 2012
ROPINIROLE HYDROCHLORIDE×5WATSON LABS INCANDA 200431Jun 06, 2012
ROPINIROLE HYDROCHLORIDE×5ACTAVIS ELIZABETHANDA 090869ABMay 17, 2012
ROPINIROLE HYDROCHLORIDE×7MLVANDA 079165ABFeb 07, 2012
ROPINIROLE HYDROCHLORIDE×7ALEMBIC LTDANDA 090429ABMar 24, 2010
ROPINIROLE HYDROCHLORIDE×7GLENMARK PHARMS LTDANDA 090135ABFeb 25, 2010
ROPINIROLE HYDROCHLORIDE×7ZYDUS LIFESCIENCESANDA 090411ABJun 01, 2009
ROPINIROLE HYDROCHLORIDE×7CHARTWELL RXANDA 079050ABMay 29, 2008
ROPINIROLE HYDROCHLORIDE×7EPIC PHARMA LLCANDA 078230May 20, 2008
ROPINIROLE HYDROCHLORIDE×7COSETTEANDA 077460May 05, 2008
ROPINIROLE HYDROCHLORIDE×7HIKMAANDA 077852May 05, 2008
ROPINIROLE HYDROCHLORIDE×7PHARMOBEDIENTANDA 078881May 05, 2008
ROPINIROLE HYDROCHLORIDE×7PRINSTON INCANDA 078110ABMay 05, 2008

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ropinirole hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.